For example, miR-765 reportedly targets the CDK2 gene, and inhibits cell migration and tube formation in osteosarcoma cells [33], and cell proliferation, migration, and invasion in breast carcinoma cells [34]. Here, CDK2 is linked to osteosarcoma.